Endoscopic lung volume reduction: Implementation and practical considerations

Khaled M. Nada, Gisele Lombard, Shawn P.E. Nishi

Research output: Contribution to journalArticlepeer-review


Guidelines for treatment in severe chronic obstructive pulmonary disease with hyperinflation now include endobronchial lung volume reduction. Since December 2018, 2 valve systems have been Food and Drug Administration (FDA) approved, which has generated widespread interest in this new therapy for chronic obstructive pulmonary disease treatment. Although the technical placement of the endobronchial valves is relatively straightforward, this paper focuses on the multidisciplinary approach to identification, evaluation, and follow-up in addition to procedural techniques for endoscopic lung volume reduction implementation.

Original languageEnglish (US)
Pages (from-to)21-25
Number of pages5
JournalClinical Pulmonary Medicine
Issue number1
StatePublished - 2020


  • COPD
  • endobronchial lung volume reduction
  • lung valve

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine
  • Critical Care and Intensive Care Medicine


Dive into the research topics of 'Endoscopic lung volume reduction: Implementation and practical considerations'. Together they form a unique fingerprint.

Cite this